Watch Ticker

Rani Therapeutics Holdings, Inc. Class A Common Stock

Go to Rani Therapeutics Holdings, Inc. Class A Common Stock Website

$0.54

-0.01 (-1.30%)

Live

Previous Close

$0.548

Day Range

$0.52 - $0.5756

Previous Day Range

$0.5116 - $0.5592

Market Cap

$23.0 million USD

Day Vol.

651113

Previous Day Vol.

673204

Currency

USD

Primary Exchange

Nasdaq

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to pain...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Rani Therapeutics, LLC - Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

~ New RT-114 obesity program combines ProGen’s FC Fusion protein conjugated GLP-1/GLP-2 dual agonist, PG-102, with the RaniPill® capsule designed to provide a differentiated oral delivery mechanism with bioavailability comparable to subcutaneous injection ~

Related tickers: RANI.

Read Full Article

Rani Therapeutics, LLC - Rani Therapeutics to Participate in May Investor Conferences

SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in two upcoming investor conferences in May 2024. These conferences include:

Related tickers: RANI.

Read Full Article

Trending Tickers

Please sign in to view